Citigroup’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
Other funds holding LOXO
Citigroup's LOXO Position: Q1 2019 in Review
Citigroup sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 54,619 shares — an estimated $7.65M sold.
Citigroup first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $7.65M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Citigroup reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Citigroup sold 54,619 Loxo Oncology, Inc shares in Q1 2019, an estimated $7.65M.
- Citigroup first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
- Citigroup's Loxo Oncology, Inc position peaked at $7.65M in Q4 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.